David B Sarwer1, Scott Ritter, Thomas A Wadden, Jacqueline C Spitzer, Marion L Vetter, Reneé H Moore. 1. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: dsarwer@mail.med.upenn.edu.
Abstract
BACKGROUND: Despite increasing awareness within the medical community about the benefits of bariatric surgery for type 2 diabetes mellitus (T2DM), little is known about patients' attitudes toward bariatric surgery as a treatment for T2DM. The objective of this study was to investigate the attitudes of individuals with T2DM and a body mass index of 30 to 40 kg/m(2) concerning bariatric surgery for the treatment of T2DM. METHODS: Patients identified from the Pennsylvania Integrated Clinical and Administrative Research Database (PICARD) were surveyed about perceptions of the safety profile and efficacy of bariatric surgery as a treatment for obesity and T2DM and their willingness to be randomly assigned to receive a surgical procedure. RESULTS:A total of 130 individuals of 513 (25.3%) responded. Respondents had a median (interquartile range) age of 58.0 (range 51.0-63.0) years and self-reported body mass index of 32.9 (range 30.9-35.2) kg/m(2). Roughly half (66 of 130) were female. Overall, only 20.3% of respondents had positive views of bariatric surgery, with few reporting that it is a safe (14.3%) and effective (28.5%) treatment for T2DM. Less than 20% of respondents were willing to be randomly assigned to undergo a surgical procedure for the treatment of diabetes (16.1%) or obesity (17.5%). CONCLUSIONS:Few obese individuals with T2DM who responded to the survey had positive views about bariatric surgery. Patients' concerns about the procedure's safety profile and efficacy must be addressed to improve the acceptability of bariatric surgery as well as the feasibility of randomized, controlled trials of bariatric surgery for these individuals.
RCT Entities:
BACKGROUND: Despite increasing awareness within the medical community about the benefits of bariatric surgery for type 2 diabetes mellitus (T2DM), little is known about patients' attitudes toward bariatric surgery as a treatment for T2DM. The objective of this study was to investigate the attitudes of individuals with T2DM and a body mass index of 30 to 40 kg/m(2) concerning bariatric surgery for the treatment of T2DM. METHODS:Patients identified from the Pennsylvania Integrated Clinical and Administrative Research Database (PICARD) were surveyed about perceptions of the safety profile and efficacy of bariatric surgery as a treatment for obesity and T2DM and their willingness to be randomly assigned to receive a surgical procedure. RESULTS: A total of 130 individuals of 513 (25.3%) responded. Respondents had a median (interquartile range) age of 58.0 (range 51.0-63.0) years and self-reported body mass index of 32.9 (range 30.9-35.2) kg/m(2). Roughly half (66 of 130) were female. Overall, only 20.3% of respondents had positive views of bariatric surgery, with few reporting that it is a safe (14.3%) and effective (28.5%) treatment for T2DM. Less than 20% of respondents were willing to be randomly assigned to undergo a surgical procedure for the treatment of diabetes (16.1%) or obesity (17.5%). CONCLUSIONS: Few obese individuals with T2DM who responded to the survey had positive views about bariatric surgery. Patients' concerns about the procedure's safety profile and efficacy must be addressed to improve the acceptability of bariatric surgery as well as the feasibility of randomized, controlled trials of bariatric surgery for these individuals.
Authors: Jeffrey I Mechanick; Robert F Kushner; Harvey J Sugerman; J Michael Gonzalez-Campoy; Maria L Collazo-Clavell; Safak Guven; Adam F Spitz; Caroline M Apovian; Edward H Livingston; Robert Brolin; David B Sarwer; Wendy A Anderson; John Dixon Journal: Surg Obes Relat Dis Date: 2008-08-19 Impact factor: 4.734
Authors: David B Sarwer; Scott Ritter; Thomas A Wadden; Jacqueline C Spitzer; Marion L Vetter; Reneé H Moore Journal: Surg Obes Relat Dis Date: 2012-01-30 Impact factor: 4.734
Authors: Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge Journal: Am J Med Date: 2009-03 Impact factor: 4.965
Authors: Yoav Avidor; Christopher D Still; Mark Brunner; Jane N Buchwald; Henry Buchwald Journal: Surg Obes Relat Dis Date: 2007-04-18 Impact factor: 4.734
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Daniel P Schauer; David E Arterburn; Ruth Wise; William Boone; David Fischer; Mark H Eckman Journal: Surg Obes Relat Dis Date: 2013-09-30 Impact factor: 4.734
Authors: Naji Alamuddin; Marion L Vetter; Rexford S Ahima; Louise Hesson; Scott Ritter; Alyssa Minnick; Lucy F Faulconbridge; Kelly C Allison; David B Sarwer; Jesse Chittams; Noel N Williams; Matthew R Hayes; James W Loughead; Ruben Gur; Thomas A Wadden Journal: Obes Surg Date: 2017-06 Impact factor: 4.129
Authors: Anita P Courcoulas; Susan Z Yanovski; Denise Bonds; Thomas L Eggerman; Mary Horlick; Myrlene A Staten; David E Arterburn Journal: JAMA Surg Date: 2014-12 Impact factor: 14.766
Authors: Bryan J Sandler; Laurent Biertho; Mehran Anvari; Roberto Rumbaut; Luis Alonso Morales-Garza; Gustavo Torres-Barrera; Simon Marceau; Dennis Hong; C Daniel Smith; Santiago Horgan Journal: Surg Endosc Date: 2018-04-20 Impact factor: 4.584